About EGeen International
EGeen International is a privately held emerging biotechnology company focused on drug and diagnostic target discovery, and personalized medicine applications. EGeen has exclusive commercial rights to the information from the Estonian Genome Project, a major national effort in Estonia with the objective of gathering medical information and blood samples from consented population. The Company will continue to establish biopharmaceutical and pharmacogenetic collaborations with partners seeking to validate drug target candidates and genetic drug profiles. More information about the Company can be found at http://www.egeeninc.com
Missing: EGeen International's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: EGeen International's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing EGeen International
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EGeen International is included in 1 Expert Collection, including Biopharma Tech.
EGeen International Web Traffic
EGeen International Rank
EGeen International Frequently Asked Questions (FAQ)
When was EGeen International founded?
EGeen International was founded in 2001.
Where is EGeen International's headquarters?
EGeen International's headquarters is located at 1949 Landings Drive, Mountain View.
What is EGeen International's latest funding round?
EGeen International's latest funding round is Unattributed VC - II.
How much did EGeen International raise?
EGeen International raised a total of $4.5M.
Who are the investors of EGeen International?
Investors of EGeen International include Ambient Sound Investments, BaltCap, Pentameter Investments, SEAF, ePlanet Capital and 7 more.
Who are EGeen International's competitors?
Competitors of EGeen International include NGM Biopharmaceuticals, Calibrant Biosystems, Merrimack Pharmaceuticals, PregLem, Laureate Pharma and 11 more.
Compare EGeen International to Competitors
RevDia is a provider of a therapeutic diagnostic testing platform. The company's diagnostic testing platform is designed to detect an active periodontal infection. Its technology is intended to measure elevated levels of slgA in saliva that is specific to Aa and Pg virulence proteins, an attribute displayed by bacteria when it becomes pathogenic during an active infection.
Idiomics, LLC is a biotechnology company providing health providers, healthcare payors and pharmaceutical companies informatics and biotechnology tools and platforms to personalize medical care to the individual patient.
MODA Technology Partners is a provider of informatics solutions for pharmaceutical and biotechnology quality manufacturing
Personalized medicine through population genomics and informatics.
Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is working on discoveries in immunotherapy science. QI is dedicated to the research, development and production of technologies that focus on the treatments and diagnoses of cancer and other diseases related to the immune system. Leveraging an expansive pipeline of biopharmaceutical innovations, QI remains committed to advancing medicine with the ultimate goal of dramatically improving lives.
Oceanit creates solutions through engineering consulting in civil, coastal, and environmental engineering; information systems consulting; management consulting, including Design Thinking and scientific research.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.